In ATTAIN-1, the investigational once-daily oral pill showed significant efficacy, and a safety and tolerability profile consistent with injectable GLP-1 therapies at 72 weeks. Orforglipron achieved the primary and all key secondary endpoints, including demonstrating improvements Read More
Dubai, UAE, 15 August 2025 As children across the UAE return to classrooms this month, Barraquer Eye Hospital UAE is urging parents and educators to take a closer look, literally, at the impact of screens on young Read More
Pirtobrutinib met the primary endpoint of response rate non-inferiority, favoring pirtobrutinib with a nominal P-value for superiority < 0.05. Progression-free survival data was immature, but trending in favor of pirtobrutinib. BRUIN CLL-314 is the first-ever head-to-head Read More
India, 11th August 2025 Eyestem Research Pvt Ltd has raised funds in a significantly oversubscribed funding round to support the next stage of development for its investigational retinal pigment epithelial (RPE) cell therapy, Eyecyte-RPE™. The capital Read More
Dubai, UAE, 25 July 2025 Nooria, the premium Swiss dietary supplement brand known for its clean, science-backed formulations, has officially launched its Personalized Supplement Program in the UAE. This innovative solution offers a tailor-made supplement plan designed Read More
